Insights from 2023 ASH Annual Meeting
A

Treatment Strategies for Hematocrit Control in PV

By Insights from 2023 ASH Annual Meeting FEATURING Amy Zhou
By Insights from 2023 ASH Annual Meeting FEATURING Amy Zhou
681 views
January 8, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Related Content

AUTOPLAY
24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
16:18
Masterclasses in Dermatology

Masterclasses from the Wards

Feat. S. Elman
24:27
BMFcases

Experts Discuss Pros and Cons of Treatment Approaches in PV

Feat. T. Bat, A. Tefferi
06:00
2024 Clinical Case Studies

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

Feat. A. Geisler
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
23:35
University of Colorado Division of Hematology

2024 Updates in PV/ET

Feat. B. McMahon
17:07
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their…

Feat. M. Minnema
05:20
Prithviraj Bose

When to Switch From Hydroxyurea to Ruxolitinib in PV

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
17:21
Daniel Addison

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

19:00
Indy Hematology Review

Waldenstrom’s Macroglobulinemia: Approaching the Newly Diagnosed and…

Feat. S. Treon
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
05:38
GRACE

Epcoritamab in NHL - Incidence and Management of CRS

Feat. T. Phillips
06:51
Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Feat. D. Tremblay
13:34
EULAR 2023 Insights

EULAR 2023 Insights: From Pathogenesis to Therapy in Sjögren's …

Feat. H. Bootsma
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein